News Sentiment

CLDX sentiment intelligence

Celldex Therapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 59 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 39.11 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

83/100 classification confidence.

Company focus 51

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

+1.9% over one week, +25.1% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Celldex Therapeutics CFO Plans to Retire in 2027

Market Reaction

Balanced read

64/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 83/100 classification
One-week reaction 1.9% Price digesting
Trend fit Trend active 25.1% over four weeks
Fair value 31.8% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 15
Neutral 41
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 51
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 22
Market source 9
TradingView 6
GlobeNewswire 5
simplywall.st 4
MT Newswires 2
Sahm 2
marketscreener.com 2

Event Lens

What the news is about

Classified themes
Market update 38
Earnings 14
Deals and strategy 3
Regulatory and legal 2
Balance sheet 1
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-59 of 59
marketscreener.com Direct company coverage

Celldex Therapeutics, Inc.(NasdaqCM: CLDX) added to Russell 3000E Growth Benchmark

Celldex Therapeutics, Inc. (NasdaqCM: CLDX) has been added to the Russell 3000E Growth Benchmark, as announced on June 28, 2026. This news follows several other recent updates for the clinical-stage biotechnology company, including presentations of long-term barzolvolimab results

Tone
Positive 74/100
Event
Earnings
Published
29 Jun 2026 03:40
Source
marketscreener.com
TradingView Direct company coverage

Enterprise value to EBIT forward of Celldex Therapeutics, Inc. – NASDAQ:CLDX

This article provides an overview of Celldex Therapeutics, Inc. (NASDAQ: CLDX) focusing on its enterprise value to EBIT forward. The content appears to be a financial data page from TradingView, offering financial metrics and other related company information.

Tone
Neutral 50/100
Event
Market update
Published
28 Jun 2026 16:39
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Celldex Therapeutics, Inc. – SWB:TCE2

This article displays the "Price to earnings forward" metric for Celldex Therapeutics, Inc. (SWB:TCE2) on the TradingView platform. The page shows that the market is closed, with no trades, and provides navigations related to financial data, news, community, forecasts, and other

Tone
Neutral 50/100
Event
Earnings
Published
28 Jun 2026 03:10
Source
TradingView
marketscreener.com Direct company coverage

Celldex Therapeutics, Inc.(NasdaqCM: CLDX) added to Russell 2000 Growth Benchmark

Celldex Therapeutics, Inc. (NasdaqCM: CLDX) has been added to the Russell 2000 Growth Benchmark. This news highlights the company's inclusion in a significant small-cap growth index, signaling increased visibility and potential interest from growth-focused investors. The clinical

Tone
Positive 70/100
Event
Market update
Published
27 Jun 2026 14:09
Source
marketscreener.com
Stock Titan Direct company coverage

Celldex (CLDX) shareholders back larger equity plan and all directors

Celldex Therapeutics, Inc. shareholders at their 2026 annual meeting approved an amendment to the 2021 Omnibus Equity Incentive Plan, increasing shares available for issuance by 3,400,000 to a total of 12,900,000 and clarifying tax withholding terms. All director nominees were el

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 13:10
Source
Stock Titan